Your browser doesn't support javascript.
loading
Non-surgical Management of Complex Refractory Pyoderma Gangrenosum With Negative Pressure Wound Therapy With Instillation.
Lee, Frank G; Song, Ethan; Wallace, Sean J; Shaughnessy, Thomas J; Raj, Mamtha; Teixeira, Robert; Miles, Marshall G; Wojcik, Randolph.
Afiliación
  • Lee FG; Division of Plastic and Reconstructive Surgery, University of South Florida Morsani College of Medicine, Tampa, USA.
  • Song E; Division of Plastic and Reconstructive Surgery, University of South Florida Morsani College of Medicine, Tampa, USA.
  • Wallace SJ; Division of Plastic and Reconstructive Surgery, Lehigh Valley Health Network, Allentown, USA.
  • Shaughnessy TJ; Department of Physical Therapy and Wound Care, Lehigh Valley Health Network, Allentown, USA.
  • Raj M; Division of Plastic and Reconstructive Surgery, Lehigh Valley Health Network, Allentown, USA.
  • Teixeira R; Division of Plastic and Reconstructive Surgery, Lehigh Valley Health Network, Allentown, USA.
  • Miles MG; Division of Plastic and Reconstructive Surgery, Lehigh Valley Health Network, Allentown, USA.
  • Wojcik R; Division of Plastic and Reconstructive Surgery, Lehigh Valley Health Network, Allentown, USA.
Cureus ; 13(10): e18951, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34815898
ABSTRACT
Pyoderma gangrenosum (PG) is a rare skin disorder primarily treated with immunosuppression medication. We report a case of a large, chronic PG wound treated with adjunct negative pressure wound therapy with instillation and dwell time (NPWTi-d) using nonadherent dressing (Mepitel) and reticular open-cell foam with through holes (ROCF-CC) with positive outcomes. The patient was a 62-year-old female with rheumatoid arthritis, Hashimoto's thyroiditis, lymphedema, and morbid obesity who presented with a 19.5 cm x 13.2 cm x 2.1 cm wound of three years duration on the right posterolateral lower extremity that successfully responded to a multimodality approach of immunosuppression and wound vac therapy. We conclude in our case that NPWTi-d with Mepitel and ROCF-CC enhanced the wound healing process, and we discuss NPWTi-d's potential role and benefit as an adjunctive therapy option for chronic and poorly controlled PG on patients taking concurrent immunosuppression.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article